» Articles » PMID: 28430987

Rab32 Subfamily Small GTPases: Pleiotropic Rabs in Endosomal Trafficking

Overview
Journal J Biochem
Specialty Biochemistry
Date 2017 Apr 22
PMID 28430987
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Rab small GTPases, well-known regulators of membrane trafficking pathways in eukaryotic cells, comprise approximately 60 different members in mammals. During the past decade, our understanding of the functions of mammalian Rab32 subfamily members (Rab32 and Rab38) have deepened, especially on the biogenesis of lysosome-related organelles, such as melanosomes, and the protection mechanisms against several pathogenic microbial infections. Endosome-mediated membrane trafficking by Rab32 subfamily members plays pivotal roles in these events. In this review, we provide an overview of the regulatory mechanisms of mammalian Rab32-family members in endosomal trafficking, especially focusing on their GEF, GAP and effector molecules, and describe the latest findings on physiological and pathological functions regulated by these molecules.

Citing Articles

LYSMD proteins promote activation of Rab32-family GTPases for lysosome-related organelle biogenesis.

Li J, Yin Q, Xuan N, Gan Q, Liu C, Zhang Q J Cell Biol. 2024; 223(10).

PMID: 39078368 PMC: 11289520. DOI: 10.1083/jcb.202402016.


Rab32 family proteins regulate autophagosomal components recycling.

Wu Z, Que H, Li C, Yan L, Wang S, Rong Y J Cell Biol. 2024; 223(3).

PMID: 38323995 PMC: 10849918. DOI: 10.1083/jcb.202306040.


A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinase.

Gustavsson E, Follett J, Trinh J, Barodia S, Real R, Liu Z medRxiv. 2024; .

PMID: 38293014 PMC: 10827257. DOI: 10.1101/2024.01.17.24300927.


Rab32 and Rab38 maintain bone homeostasis by regulating intracellular traffic in osteoclasts.

Tokuda K, Lu S, Zhang Z, Kato Y, Chen S, Noda K Cell Struct Funct. 2023; 48(2):223-239.

PMID: 37793839 PMC: 11496785. DOI: 10.1247/csf.23061.


Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.

Kalashyan M, Raghunathan K, Oller H, Bayer M, Jimenez L, Roland J J Clin Invest. 2023; 133(20).

PMID: 37643022 PMC: 10575727. DOI: 10.1172/JCI169234.